Percutaneous VA-ECMO from Cannulation to Decannulation: Novel Use of a Vascular Closure Device in Pediatrics

Pediatr Cardiol. 2023 Oct;44(7):1623-1628. doi: 10.1007/s00246-023-03222-w. Epub 2023 Jul 7.

Abstract

VA-ECMO can be lifesaving in cardiogenic shock in children. While surgical vascular repair is the current standard of care for decannulation, it comes with notable risks. We present a series of eight patients who underwent decannulation with a collagen plug-based vascular closure device (MANTA) for the common femoral artery. Seven of the patients were successfully decannulated without access site-related vascular complications. One required conversion to surgical cut-down with arterial repair due to device failure. This series demonstrates the successful use of the MANTA device in percutaneous VA-ECMO decannulation in the pediatric population, while highlighting potential technical challenges for success.

Keywords: ECMO decannulation; MANTA device; Perclose ProGlide device.

MeSH terms

  • Catheterization, Peripheral* / adverse effects
  • Child
  • Extracorporeal Membrane Oxygenation* / adverse effects
  • Femoral Artery / surgery
  • Humans
  • Pediatrics*
  • Retrospective Studies
  • Treatment Outcome
  • Vascular Closure Devices*